_:necd597d446a74bb6bd95f82058193fa8xb2
<http://schema.org/text>
"[i]&nbsp;Slominski A., Zmijewski M., Pawelek J. &ldquo;L-tyrosine and L-DOPA as hormone-like regulators of melanocytes functions&rdquo;&nbsp;Pigment Cell Melanoma Research. 2012 Jan; 25(1): 14&ndash;27. (source)\r\n[ii]&nbsp;&ldquo;Phenylalanine&rdquo;&nbsp;University of Maryland Medical Centerumm.edu/health (source)\r\n[iii]&nbsp;Hase A., Jung S.E., aan het Rot M. &ldquo;Behavioral and cognitive effects of tyrosine intake in healthy human adults.&rdquo;&nbsp;Pharmacology, Biochemistry and Behavior. 2015 Jun;133:1-6. (source)\r\n[iv]&nbsp;Meisburger S.P., Taylor A.B., Khan C.A., Zhang S., Fitzpatrick P.F., Ando N. &ldquo;Domain Movements upon Activation of Phenylalanine Hydroxylase Characterized by Crystallography and Chromatography-Coupled Small-Angle X-ray Scattering.&rdquo;&nbsp;Journal of the American Chemical Society. 2016 May 25;138(20):6506-16. (source)\r\n[v]&nbsp;Tavernier G. et. Al. &ldquo;Norepinephrine Induces Lipolysis in &beta;1/&beta;2/&beta;3-Adrenoceptor Knockout Mice&rdquo;&nbsp;Molecular Pharmacology&nbsp;September 2005 vol. 68 no. 3 793-799 (source)\r\n[vi]&nbsp;Walsh N.E., Ramamurthy S., Schoenfeld L., Hoffman J. &ldquo;Analgesic effectiveness of D-phenylalanine in chronic pain patients.&rdquo;&nbsp;Archives of Physical Medicine and Rehabilitation. 1986 Jul;67(7):436-9. (source)\r\n[vii]&nbsp;Beckmann H., Ludolph E. in German &ldquo;[DL-phenylalanine as an antidepressant. Open study (author&rsquo;s transl)].&rdquo;&nbsp;Arzneimittelforschung. 1978;28(8):1283-4. (source)\r\n[viii]&nbsp;Zavala M., Castej&oacute;n H.V., Ortega P.A., Castej&oacute;n O.J., Marcano de Hidalgo A., Montiel N. in Spanish &ldquo;[Imbalance of plasma amino acids in patients with autism and subjects with attention deficit/hyperactivity disorder].&rdquo;&nbsp;Revista de Neurologica. 2001 Sep 1-15;33(5):401-8. (source)\r\n[ix]&nbsp;Bornstein R.A., Baker G.B., Carroll A., King G., Wong J.T., Douglass A.B. &ldquo;Plasma amino acids in attention deficit disorder.&rdquo;&nbsp;Psychiatry Research. 1990 Sep;33(3):301-6. (source)\r\n[x]&nbsp;Fischer E., Heller B., Nachon M., Spatz H. &ldquo;Therapy of depression by phenylalanine. Preliminary note.&rdquo;&nbsp;Arzneimittelforschung. 1975 Jan;25(1):132. (source)\r\n[xi]&nbsp;Beckmann H., Strauss M.A., Ludolph E. &ldquo;Dl-phenylalanine in depressed patients: an open study.&rdquo;&nbsp;Journal of Neural Transmission. 1977;41(2-3):123-34. (source)\r\n[xii]&nbsp;Wood D.R., Reimherr F.W., Wender P.H. &ldquo;Treatment of attention deficit disorder with DL-phenylalanine.&rdquo;&nbsp;Psychiatry Research. 1985 Sep;16(1):21-6. (source)\r\n[xiii]&nbsp;Zametkin A.J., Karoum F., Rapoport J.L. &ldquo;Treatment of hyperactive children with D-phenylalanine.&rdquo;&nbsp;American Journal of Psychiatry. 1987 Jun;144(6):792-4. (source)\r\n[xiv]&nbsp;&ldquo;Phenylalanine&rdquo;&nbsp;University of Maryland Medical Center&nbsp;umm.edu Retrieved July 7, 2016 (source)"
<https://nootropicsexpert.com/phenylalanine/comment-page-1/?replytocom=1705>